Literature DB >> 32958468

Patients use fewer analgesics following supervised exercise therapy and patient education: an observational study of 16 499 patients with knee or hip osteoarthritis.

Jonas Bloch Thorlund1,2, Ewa M Roos3, Patricia Goro4, Emily Gromelsky Ljungcrantz4, Dorte Thalund Grønne3, Søren T Skou3,5.   

Abstract

OBJECTIVES: To investigate changes in analgesic use before and after supervised exercise therapy and patient education in patients with knee or hip osteoarthritis (OA).
METHODS: We recruited 16 499 of 25 933 eligible patients (64%; mean age 64.9; SD 9.6; 73% women) from the Good Life with osteoArthritis in Denmark (GLA:D) registry. Change in proportions of analgesic users (categorised according to analgesic risk profile; opioids > non-steroidal anti-inflammatory drugs > paracetamol) was assessed from before to after an 8-week supervised exercise therapy and patient education programme targeting knee or hip OA pain and functional limitations.
RESULTS: Patients reported 13.2 mm (95% CI 12.8 to 13.6) less pain (visual analogue scale 0-100 mm) at follow-up compared with baseline. The proportion of analgesic users reduced from 62.2% (95% CI 61.5 to 63.0) at baseline to 44.1% (95% CI 43.3 to 44.9) at follow-up (absolute change: 18.1% (95% CI 17.3 to 19.0)). Among patients using analgesics at baseline, 52% changed to a lower risk analgesic or discontinued analgesic use. The proportion of opioid users after the exercise therapy was 2.5% (95% CI 2.1 to 2.9) lower than baseline; this represents a relative reduction of 36%.
CONCLUSION: Among patients with knee or hip OA using analgesics, more than half either discontinued analgesic use or shifted to lower risk analgesics following an 8-week structured exercise therapy and patient education programme (GLA:D). These data encourage randomised controlled trial evaluation of whether supervised exercise therapy, combined with patient education, can reduce analgesic use, including opioids, among patients with knee and hip OA pain. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology; physiotherapy

Mesh:

Substances:

Year:  2020        PMID: 32958468     DOI: 10.1136/bjsports-2019-101265

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  5 in total

1.  Depressive symptoms and multi-joint pain partially mediate the relationship between obesity and opioid use in people with knee osteoarthritis.

Authors:  L C Carlesso; S R Jafarzadeh; A Stokes; D T Felson; N Wang; L Frey-Law; C E Lewis; M Nevitt; T Neogi
Journal:  Osteoarthritis Cartilage       Date:  2022-06-11       Impact factor: 7.507

2.  Does Pain Medication Use Influence the Outcome of 8 Weeks of Education and Exercise Therapy in Patients with Knee or Hip Osteoarthritis? An Observational Study.

Authors:  Bart W Koes; Alessandro Chiarotto; Jonas Bloch Thorlund; Dorte Thalund Grønne; Ewa M Roos; Søren T Skou
Journal:  Pain Med       Date:  2022-08-01       Impact factor: 3.637

3.  Physical Activity is Associated with Less Analgesic Use in Women Reporting Headache-A Cross-Sectional Study of the German Migraine and Headache Society (DMKG).

Authors:  Britta Müller; Charly Gaul; Änne Glass; Olaf Reis; Tim P Jürgens; Peter Kropp; Ruth Ruscheweyh; Andreas Straube; Elmar Brähler; Stefanie Förderreuther; Thomas Dresler
Journal:  Pain Ther       Date:  2022-02-25

4.  Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis.

Authors:  Nicholas Avery; Amy G McNeilage; Fiona Stanaway; Claire E Ashton-James; Fiona M Blyth; Rebecca Martin; Ali Gholamrezaei; Paul Glare
Journal:  BMJ       Date:  2022-04-04

5.  Effectiveness of Internet-Based Exercises Aimed at Treating Knee Osteoarthritis: The iBEAT-OA Randomized Clinical Trial.

Authors:  Sameer Akram Gohir; Frida Eek; Anthony Kelly; Abhishek Abhishek; Ana M Valdes
Journal:  JAMA Netw Open       Date:  2021-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.